Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prisoners | 3 | 2024 | 316 | 1.540 |
Why?
|
Specialties, Surgical | 2 | 2024 | 391 | 1.230 |
Why?
|
Immunotherapy | 6 | 2024 | 4755 | 1.170 |
Why?
|
Carcinoma, Ductal, Breast | 2 | 2024 | 1099 | 1.020 |
Why?
|
Internship and Residency | 5 | 2024 | 5953 | 0.870 |
Why?
|
Antigens, Surface | 9 | 2005 | 1617 | 0.830 |
Why?
|
Immunoglobulin Class Switching | 1 | 2024 | 289 | 0.810 |
Why?
|
Inflammatory Breast Neoplasms | 1 | 2024 | 150 | 0.800 |
Why?
|
General Surgery | 2 | 2024 | 1720 | 0.760 |
Why?
|
Students, Medical | 3 | 2023 | 1964 | 0.710 |
Why?
|
Plasma Cells | 1 | 2024 | 599 | 0.710 |
Why?
|
Cyclonic Storms | 1 | 2021 | 121 | 0.680 |
Why?
|
Carcinoma, Lobular | 1 | 2024 | 480 | 0.680 |
Why?
|
Cultural Diversity | 1 | 2023 | 373 | 0.670 |
Why?
|
Job Description | 1 | 2019 | 61 | 0.660 |
Why?
|
Interleukins | 1 | 2024 | 796 | 0.640 |
Why?
|
Terrorism | 1 | 2021 | 211 | 0.590 |
Why?
|
Immunoglobulin E | 1 | 2024 | 1506 | 0.580 |
Why?
|
Faculty, Medical | 2 | 2023 | 1226 | 0.580 |
Why?
|
Leadership | 2 | 2023 | 1397 | 0.570 |
Why?
|
Clinical Clerkship | 1 | 2023 | 569 | 0.560 |
Why?
|
Physicians, Women | 1 | 2023 | 517 | 0.560 |
Why?
|
Interviews as Topic | 1 | 2024 | 2741 | 0.550 |
Why?
|
Mentors | 1 | 2022 | 671 | 0.530 |
Why?
|
Emigrants and Immigrants | 1 | 2023 | 550 | 0.520 |
Why?
|
Breast Neoplasms | 5 | 2024 | 21206 | 0.520 |
Why?
|
Disaster Planning | 1 | 2021 | 560 | 0.510 |
Why?
|
Disasters | 1 | 2021 | 521 | 0.500 |
Why?
|
Terminology as Topic | 2 | 2020 | 1542 | 0.500 |
Why?
|
Semantics | 1 | 2019 | 618 | 0.500 |
Why?
|
Radiology, Interventional | 1 | 2019 | 483 | 0.490 |
Why?
|
Laparoscopy | 2 | 2024 | 2041 | 0.480 |
Why?
|
Neoplasms | 6 | 2024 | 22371 | 0.470 |
Why?
|
Specialization | 1 | 2019 | 779 | 0.470 |
Why?
|
Tissue and Organ Procurement | 1 | 2023 | 986 | 0.460 |
Why?
|
Organ Transplantation | 1 | 2024 | 1176 | 0.460 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2024 | 2333 | 0.450 |
Why?
|
Education, Medical, Undergraduate | 1 | 2023 | 1085 | 0.450 |
Why?
|
Sarcoma | 1 | 2024 | 1806 | 0.420 |
Why?
|
Career Choice | 3 | 2024 | 769 | 0.410 |
Why?
|
Medicine | 1 | 2020 | 945 | 0.400 |
Why?
|
Immunoglobulin G | 1 | 2024 | 4568 | 0.400 |
Why?
|
Liver Neoplasms | 3 | 2024 | 4362 | 0.380 |
Why?
|
Basic-Leucine Zipper Transcription Factors | 1 | 2011 | 153 | 0.360 |
Why?
|
Sirtuin 1 | 1 | 2011 | 247 | 0.340 |
Why?
|
United States | 14 | 2024 | 73039 | 0.330 |
Why?
|
CD8-Positive T-Lymphocytes | 5 | 2011 | 4648 | 0.310 |
Why?
|
Molecular Targeted Therapy | 2 | 2019 | 2830 | 0.290 |
Why?
|
Humans | 47 | 2024 | 768166 | 0.290 |
Why?
|
Immunologic Factors | 1 | 2017 | 1596 | 0.290 |
Why?
|
Southeastern United States | 2 | 2024 | 93 | 0.290 |
Why?
|
Cell Differentiation | 3 | 2024 | 11669 | 0.280 |
Why?
|
Practice Guidelines as Topic | 1 | 2024 | 7454 | 0.270 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1169 | 0.270 |
Why?
|
Interleukin-18 | 1 | 2008 | 251 | 0.270 |
Why?
|
Blood Proteins | 5 | 2004 | 1191 | 0.260 |
Why?
|
Schools, Medical | 2 | 2022 | 883 | 0.240 |
Why?
|
Interferon-gamma | 5 | 2008 | 3160 | 0.240 |
Why?
|
Mastectomy, Modified Radical | 1 | 2024 | 62 | 0.230 |
Why?
|
Prisons | 2 | 2023 | 178 | 0.230 |
Why?
|
Apoptosis Regulatory Proteins | 9 | 2005 | 1151 | 0.230 |
Why?
|
Receptors, Lysophosphatidic Acid | 2 | 2014 | 78 | 0.220 |
Why?
|
School Admission Criteria | 1 | 2024 | 107 | 0.220 |
Why?
|
Texas | 1 | 2024 | 410 | 0.220 |
Why?
|
Personnel Selection | 1 | 2024 | 201 | 0.200 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5432 | 0.200 |
Why?
|
T-Lymphocytes | 7 | 2019 | 10266 | 0.200 |
Why?
|
Peptides | 7 | 2008 | 4354 | 0.200 |
Why?
|
Genetic Loci | 1 | 2011 | 2629 | 0.200 |
Why?
|
Palatine Tonsil | 1 | 2002 | 193 | 0.200 |
Why?
|
Police | 2 | 2022 | 158 | 0.190 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26379 | 0.190 |
Why?
|
Melanoma, Experimental | 1 | 2004 | 559 | 0.190 |
Why?
|
Immunologic Memory | 1 | 2008 | 1377 | 0.190 |
Why?
|
Pandemics | 4 | 2022 | 8748 | 0.180 |
Why?
|
Retrospective Studies | 8 | 2024 | 81762 | 0.180 |
Why?
|
Female | 21 | 2024 | 397192 | 0.180 |
Why?
|
Neoplasms, Experimental | 2 | 2004 | 1230 | 0.180 |
Why?
|
Synovial Membrane | 2 | 2014 | 536 | 0.180 |
Why?
|
Metaphor | 1 | 2020 | 41 | 0.180 |
Why?
|
Immune Tolerance | 4 | 2013 | 2323 | 0.180 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2004 | 1801 | 0.180 |
Why?
|
Interleukin-4 | 1 | 2024 | 1156 | 0.170 |
Why?
|
rap GTP-Binding Proteins | 1 | 2019 | 24 | 0.160 |
Why?
|
Genetic Counseling | 1 | 2023 | 635 | 0.160 |
Why?
|
Antineoplastic Agents | 4 | 2017 | 13676 | 0.160 |
Why?
|
Policy | 1 | 2023 | 513 | 0.160 |
Why?
|
Altruism | 1 | 2020 | 211 | 0.150 |
Why?
|
New York | 1 | 2020 | 882 | 0.150 |
Why?
|
Lymph Node Excision | 1 | 2024 | 1271 | 0.150 |
Why?
|
Genital Neoplasms, Female | 1 | 2023 | 536 | 0.150 |
Why?
|
Epigenesis, Genetic | 1 | 2011 | 3833 | 0.150 |
Why?
|
Fibronectins | 2 | 2019 | 722 | 0.150 |
Why?
|
Lung Neoplasms | 3 | 2018 | 13586 | 0.140 |
Why?
|
Adenoma, Pleomorphic | 1 | 2018 | 77 | 0.140 |
Why?
|
Virus Diseases | 1 | 2003 | 724 | 0.140 |
Why?
|
Mastectomy, Segmental | 1 | 2022 | 974 | 0.140 |
Why?
|
Healthcare Disparities | 2 | 2024 | 3415 | 0.140 |
Why?
|
Male | 15 | 2024 | 364719 | 0.130 |
Why?
|
Solubility | 1 | 2018 | 1083 | 0.130 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1667 | 0.130 |
Why?
|
Cell Proliferation | 4 | 2015 | 10474 | 0.130 |
Why?
|
Animals | 20 | 2024 | 169246 | 0.120 |
Why?
|
Soft Tissue Neoplasms | 1 | 2024 | 1164 | 0.120 |
Why?
|
Glycosylation | 1 | 2018 | 1100 | 0.120 |
Why?
|
Adult | 9 | 2024 | 223646 | 0.120 |
Why?
|
Mice | 15 | 2024 | 82029 | 0.120 |
Why?
|
Receptors, Notch | 1 | 2019 | 751 | 0.110 |
Why?
|
Signal Transduction | 7 | 2020 | 23645 | 0.110 |
Why?
|
Guideline Adherence | 1 | 2024 | 2235 | 0.110 |
Why?
|
Fibroblasts | 2 | 2014 | 4176 | 0.110 |
Why?
|
Movement | 1 | 2021 | 1490 | 0.110 |
Why?
|
Dopamine | 1 | 2020 | 1592 | 0.110 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2018 | 3814 | 0.110 |
Why?
|
Nephritis, Interstitial | 1 | 2014 | 158 | 0.110 |
Why?
|
Students | 1 | 2023 | 1744 | 0.100 |
Why?
|
Zebrafish Proteins | 1 | 2019 | 1019 | 0.100 |
Why?
|
Antigens, CD | 8 | 2008 | 4035 | 0.100 |
Why?
|
Cell Adhesion | 1 | 2019 | 3096 | 0.100 |
Why?
|
Organoplatinum Compounds | 1 | 2014 | 408 | 0.100 |
Why?
|
Lysophospholipids | 1 | 2014 | 338 | 0.100 |
Why?
|
Dendritic Cells | 3 | 2015 | 2747 | 0.100 |
Why?
|
Antibodies, Monoclonal | 6 | 2017 | 9263 | 0.100 |
Why?
|
Protein Transport | 1 | 2018 | 1951 | 0.100 |
Why?
|
Membrane Glycoproteins | 6 | 2005 | 3711 | 0.100 |
Why?
|
Anxiety Disorders | 1 | 2023 | 2748 | 0.100 |
Why?
|
Reoperation | 1 | 2022 | 4329 | 0.090 |
Why?
|
Antibodies | 2 | 2018 | 2421 | 0.090 |
Why?
|
Arthritis, Experimental | 1 | 2013 | 293 | 0.090 |
Why?
|
Liver | 2 | 2004 | 7577 | 0.090 |
Why?
|
Cisplatin | 2 | 2015 | 1660 | 0.090 |
Why?
|
Middle Aged | 7 | 2024 | 223492 | 0.090 |
Why?
|
Aged | 9 | 2024 | 171504 | 0.090 |
Why?
|
Motor Activity | 1 | 2020 | 2711 | 0.090 |
Why?
|
Blotting, Western | 1 | 2018 | 5027 | 0.090 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1883 | 0.090 |
Why?
|
Wnt Proteins | 1 | 2014 | 725 | 0.090 |
Why?
|
Genetic Testing | 1 | 2023 | 3591 | 0.090 |
Why?
|
Minor Histocompatibility Antigens | 2 | 2008 | 303 | 0.090 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2010 | 50 | 0.090 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3929 | 0.080 |
Why?
|
Medical Oncology | 1 | 2022 | 2346 | 0.080 |
Why?
|
Curriculum | 1 | 2023 | 3782 | 0.080 |
Why?
|
Communication | 1 | 2024 | 3905 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2015 | 724 | 0.080 |
Why?
|
Pilot Projects | 1 | 2023 | 8741 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2015 | 5341 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2024 | 4055 | 0.080 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2010 | 151 | 0.080 |
Why?
|
Interleukin-12 | 1 | 2011 | 577 | 0.080 |
Why?
|
Acetylation | 1 | 2011 | 1056 | 0.080 |
Why?
|
Cytokines | 4 | 2014 | 7453 | 0.080 |
Why?
|
Immune System | 1 | 2013 | 799 | 0.080 |
Why?
|
Lectins, C-Type | 2 | 2008 | 594 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3114 | 0.070 |
Why?
|
NAD | 1 | 2011 | 618 | 0.070 |
Why?
|
B-Lymphocytes | 3 | 2013 | 4793 | 0.070 |
Why?
|
Delivery of Health Care | 2 | 2021 | 5367 | 0.070 |
Why?
|
Hematopoietic Stem Cells | 1 | 2019 | 3409 | 0.070 |
Why?
|
Health Personnel | 1 | 2020 | 3385 | 0.070 |
Why?
|
Protein Multimerization | 1 | 2011 | 965 | 0.070 |
Why?
|
Lymphocyte Depletion | 1 | 2008 | 605 | 0.060 |
Why?
|
Arthritis, Rheumatoid | 3 | 2014 | 3781 | 0.060 |
Why?
|
Case-Control Studies | 1 | 2024 | 22291 | 0.060 |
Why?
|
Antigens, Differentiation | 3 | 2004 | 921 | 0.060 |
Why?
|
Mice, Knockout | 4 | 2013 | 14488 | 0.060 |
Why?
|
Prognosis | 2 | 2024 | 30010 | 0.060 |
Why?
|
Protein Binding | 1 | 2018 | 9343 | 0.060 |
Why?
|
Mice, Transgenic | 3 | 2008 | 9561 | 0.060 |
Why?
|
Pain | 1 | 2020 | 5100 | 0.060 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2004 | 0.060 |
Why?
|
Follow-Up Studies | 2 | 2024 | 39348 | 0.060 |
Why?
|
Lymphocyte Activation | 3 | 2004 | 5505 | 0.060 |
Why?
|
Transfection | 2 | 2002 | 5755 | 0.060 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2010 | 977 | 0.060 |
Why?
|
Salivary Glands | 1 | 2005 | 231 | 0.060 |
Why?
|
Interleukin-17 | 1 | 2010 | 924 | 0.060 |
Why?
|
Autoantigens | 1 | 2008 | 890 | 0.060 |
Why?
|
Proteins | 3 | 2003 | 6009 | 0.060 |
Why?
|
Sjogren's Syndrome | 1 | 2005 | 240 | 0.050 |
Why?
|
Kupffer Cells | 1 | 2003 | 143 | 0.050 |
Why?
|
Antibodies, Blocking | 1 | 2003 | 250 | 0.050 |
Why?
|
Clonal Anergy | 1 | 2003 | 169 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3115 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3238 | 0.050 |
Why?
|
Receptors, Cell Surface | 2 | 2008 | 2819 | 0.050 |
Why?
|
Self Tolerance | 1 | 2002 | 122 | 0.050 |
Why?
|
Tumor Escape | 1 | 2004 | 372 | 0.050 |
Why?
|
Mice, Inbred DBA | 1 | 2002 | 624 | 0.050 |
Why?
|
Propaganda | 1 | 2020 | 7 | 0.050 |
Why?
|
Synovial Fluid | 1 | 2003 | 393 | 0.050 |
Why?
|
Bone Marrow Cells | 2 | 2013 | 2414 | 0.050 |
Why?
|
Lymphoid Tissue | 1 | 2002 | 445 | 0.050 |
Why?
|
Prescriptions | 1 | 2023 | 388 | 0.050 |
Why?
|
Histones | 1 | 2011 | 2601 | 0.050 |
Why?
|
Insulin-Secreting Cells | 1 | 2008 | 899 | 0.040 |
Why?
|
Indocyanine Green | 1 | 2022 | 239 | 0.040 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2002 | 897 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2002 | 630 | 0.040 |
Why?
|
Mice, Inbred C57BL | 5 | 2013 | 22379 | 0.040 |
Why?
|
Rats, Long-Evans | 1 | 2020 | 380 | 0.040 |
Why?
|
Germinal Center | 1 | 2002 | 380 | 0.040 |
Why?
|
Mice, Inbred BALB C | 3 | 2002 | 6231 | 0.040 |
Why?
|
Kidney | 1 | 2014 | 7064 | 0.040 |
Why?
|
Faculty | 1 | 2022 | 383 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2002 | 6124 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4916 | 0.040 |
Why?
|
Child | 2 | 2023 | 80917 | 0.040 |
Why?
|
DNA-Binding Proteins | 1 | 2015 | 9615 | 0.040 |
Why?
|
Aftercare | 1 | 2023 | 916 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5703 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 11928 | 0.030 |
Why?
|
Mice, Nude | 1 | 2002 | 3623 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2014 | 19015 | 0.030 |
Why?
|
Violence | 1 | 2022 | 936 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2010 | 5804 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2002 | 975 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2004 | 2568 | 0.030 |
Why?
|
Propionates | 1 | 2014 | 180 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2022 | 1135 | 0.030 |
Why?
|
Isoxazoles | 1 | 2014 | 233 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2004 | 2541 | 0.030 |
Why?
|
Cricetulus | 1 | 2014 | 812 | 0.030 |
Why?
|
CHO Cells | 1 | 2014 | 1379 | 0.020 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2015 | 567 | 0.020 |
Why?
|
Hemorrhage | 1 | 2023 | 3467 | 0.020 |
Why?
|
Models, Immunological | 1 | 2013 | 518 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2013 | 475 | 0.020 |
Why?
|
Osteoarthritis | 2 | 2013 | 1072 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2003 | 4427 | 0.020 |
Why?
|
Cricetinae | 1 | 2014 | 2423 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2003 | 3049 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2003 | 4415 | 0.020 |
Why?
|
Patient Discharge | 1 | 2023 | 3479 | 0.020 |
Why?
|
NF-kappa B p50 Subunit | 1 | 2010 | 103 | 0.020 |
Why?
|
Fluorouracil | 1 | 2015 | 1652 | 0.020 |
Why?
|
Osteoclasts | 1 | 2013 | 713 | 0.020 |
Why?
|
Acute Disease | 2 | 2014 | 7243 | 0.020 |
Why?
|
Doxorubicin | 1 | 2015 | 2234 | 0.020 |
Why?
|
Benzamides | 1 | 2014 | 1379 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4852 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10632 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2015 | 17140 | 0.020 |
Why?
|
Zebrafish | 1 | 2019 | 3035 | 0.020 |
Why?
|
Paclitaxel | 1 | 2015 | 1733 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4580 | 0.020 |
Why?
|
Quinazolines | 1 | 2014 | 1373 | 0.020 |
Why?
|
Spleen | 1 | 2013 | 2295 | 0.020 |
Why?
|
Fibrosis | 1 | 2014 | 2080 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7598 | 0.020 |
Why?
|
Actins | 1 | 2014 | 2064 | 0.020 |
Why?
|
Th17 Cells | 1 | 2013 | 791 | 0.020 |
Why?
|
Leukocytes | 1 | 2014 | 2035 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2832 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2010 | 1340 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2015 | 3428 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2014 | 1892 | 0.020 |
Why?
|
Ligands | 2 | 2002 | 3284 | 0.020 |
Why?
|
Brain Mapping | 1 | 2020 | 6685 | 0.020 |
Why?
|
Medicare | 1 | 2023 | 6809 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5777 | 0.010 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2010 | 822 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2002 | 5196 | 0.010 |
Why?
|
Rats | 1 | 2020 | 23760 | 0.010 |
Why?
|
Flow Cytometry | 2 | 2005 | 5902 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12840 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2008 | 1837 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2018 | 59629 | 0.010 |
Why?
|
Pore Forming Cytotoxic Proteins | 1 | 2003 | 130 | 0.010 |
Why?
|
Perforin | 1 | 2003 | 167 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3139 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2003 | 216 | 0.010 |
Why?
|
Neoplasm Proteins | 1 | 2015 | 3603 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2008 | 1251 | 0.010 |
Why?
|
Cell Movement | 1 | 2014 | 5210 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8647 | 0.010 |
Why?
|
Epitopes | 1 | 2008 | 2528 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2008 | 1361 | 0.010 |
Why?
|
Transduction, Genetic | 1 | 2004 | 899 | 0.010 |
Why?
|
Time Factors | 1 | 2002 | 40218 | 0.010 |
Why?
|
Child, Preschool | 1 | 2002 | 42669 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2010 | 2909 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5797 | 0.010 |
Why?
|
Apoptosis | 1 | 2014 | 9523 | 0.010 |
Why?
|
Interleukin-10 | 1 | 2003 | 1183 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2003 | 1895 | 0.010 |
Why?
|
Risk Factors | 1 | 2023 | 74944 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7608 | 0.010 |
Why?
|
Down-Regulation | 1 | 2003 | 2937 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2003 | 2709 | 0.010 |
Why?
|
Up-Regulation | 1 | 2004 | 4146 | 0.010 |
Why?
|
Lymphocytes | 1 | 2002 | 2614 | 0.010 |
Why?
|
Autoimmunity | 1 | 2002 | 1361 | 0.010 |
Why?
|
Adolescent | 1 | 2002 | 89169 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2005 | 3703 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 2002 | 2257 | 0.010 |
Why?
|